3M introduces the new 3M VFlex Particulate Respirators 9105 and 9105S, N95. The new VFlex respirators have been designed to deliver comfort and value at an affordable price, and build on 3Ms decades of experience in the science of respiratory protection.
"As a leader in the respiratory protection category, were excited to bring another innovation to this product group," said Yolla Levitt, 3M global maintenance-free respirator marketing manager. "Not only is this product one of the most economical filtering facepiece respirators from 3M, it has been designed to provide several comfort features not generally available at this price point."
The unique v-shaped pleats on the VFlex respirators expand to help provide a comfortable seal and to flex with mouth movements for easier talking. The increased surface area of the v-shaped pleats, in combination with the 3M patented filter media, results in lower breathing resistance and helps make breathing easier.
The VFlex respirators feature embossed front panels, helping them retain their shape. The side tabs have been designed for easy positioning of the respirator on the face for a comfortable fit, and the adjustable nose clip helps provide a custom fit and secure seal. The new respirators are available in two sizes to fit a wide range of people.
For more information visit www.3M.com/VFlex.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.